These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 28446224)

  • 1. Immunosuppressive capacity of mesenchymal stem cells correlates with metabolic activity and can be enhanced by valproic acid.
    Killer MC; Nold P; Henkenius K; Fritz L; Riedlinger T; Barckhausen C; Frech M; Hackstein H; Neubauer A; Brendel C
    Stem Cell Res Ther; 2017 Apr; 8(1):100. PubMed ID: 28446224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive capabilities of mesenchymal stromal cells are maintained under hypoxic growth conditions and after gamma irradiation.
    Nold P; Hackstein H; Riedlinger T; Kasper C; Neumann A; Mernberger M; Fölsch C; Schmitt J; Fuchs-Winkelmann S; Barckhausen C; Killer M; Neubauer A; Brendel C
    Cytotherapy; 2015 Feb; 17(2):152-62. PubMed ID: 25453724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xenotransplantation of interferon-gamma-pretreated clumps of a human mesenchymal stem cell/extracellular matrix complex induces mouse calvarial bone regeneration.
    Takeshita K; Motoike S; Kajiya M; Komatsu N; Takewaki M; Ouhara K; Iwata T; Takeda K; Mizuno N; Fujita T; Kurihara H
    Stem Cell Res Ther; 2017 Apr; 8(1):101. PubMed ID: 28446226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A streamlined proliferation assay using mixed lymphocytes for evaluation of human mesenchymal stem cell immunomodulation activity.
    Herzig MC; Delavan CP; Jensen KJ; Cantu C; Montgomery RK; Christy BA; Cap AP; Bynum JA
    J Immunol Methods; 2021 Jan; 488():112915. PubMed ID: 33212091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human adipose tissue-derived mesenchymal stem cells induce explosive T-cell proliferation.
    Crop MJ; Baan CC; Korevaar SS; Ijzermans JN; Weimar W; Hoogduijn MJ
    Stem Cells Dev; 2010 Dec; 19(12):1843-53. PubMed ID: 20367242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human mesenchymal stem cells modulate cellular immune response to islet antigen glutamic acid decarboxylase in type 1 diabetes.
    Zanone MM; Favaro E; Miceli I; Grassi G; Camussi E; Caorsi C; Amoroso A; Giovarelli M; Perin PC; Camussi G
    J Clin Endocrinol Metab; 2010 Aug; 95(8):3788-97. PubMed ID: 20466784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stem cells do not suppress lymphoblastic leukemic cell line proliferation.
    Mousavi Niri N; Jaberipour M; Razmkhah M; Ghaderi A; Habibagahi M
    Iran J Immunol; 2009 Dec; 6(4):186-94. PubMed ID: 20054106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DSP30 enhances the immunosuppressive properties of mesenchymal stromal cells and protects their suppressive potential from lipopolysaccharide effects: A potential role of adenosine.
    Sangiorgi B; De Freitas HT; Schiavinato JL; Leão V; Haddad R; Orellana MD; Faça VM; Ferreira GA; Covas DT; Zago MA; Panepucci RA
    Cytotherapy; 2016 Jul; 18(7):846-59. PubMed ID: 27260206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproic acid promotes neuronal differentiation by induction of neuroprogenitors in human bone-marrow mesenchymal stromal cells.
    Jeong SG; Ohn T; Kim SH; Cho GW
    Neurosci Lett; 2013 Oct; 554():22-7. PubMed ID: 24021810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stromal cells isolated from children with systemic juvenile idiopathic arthritis suppress innate and adaptive immune responses.
    Calkoen FG; Brinkman DM; Vervat C; van Ostaijen-Ten Dam MM; Ten Cate R; van Tol MJ; Ball LM
    Cytotherapy; 2013 Mar; 15(3):280-91. PubMed ID: 23312448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow mesenchymal stromal cells isolated from multiple sclerosis patients have distinct gene expression profile and decreased suppressive function compared with healthy counterparts.
    de Oliveira GL; de Lima KW; Colombini AM; Pinheiro DG; Panepucci RA; Palma PV; Brum DG; Covas DT; Simões BP; de Oliveira MC; Donadi EA; Malmegrim KC
    Cell Transplant; 2015; 24(2):151-65. PubMed ID: 24256874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human umbilical cord-derived mesenchymal stem cells suppress proliferation of PHA-activated lymphocytes in vitro by inducing CD4(+)CD25(high)CD45RA(+) regulatory T cell production and modulating cytokine secretion.
    Yang H; Sun J; Li Y; Duan WM; Bi J; Qu T
    Cell Immunol; 2016 Apr; 302():26-31. PubMed ID: 26774852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor-derived equine mesenchymal stem cells suppress proliferation of mismatched lymphocytes.
    Ranera B; Antczak D; Miller D; Doroshenkova T; Ryan A; McIlwraith CW; Barry F
    Equine Vet J; 2016 Mar; 48(2):253-60. PubMed ID: 25582202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunosuppressive properties of non-cultured dermal-derived mesenchymal stromal cells and the control of graft-versus-host disease.
    Gao L; Liu F; Tan L; Liu T; Chen Z; Shi C
    Biomaterials; 2014 Apr; 35(11):3582-8. PubMed ID: 24468404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different roles of PD-L1 and FasL in immunomodulation mediated by human placenta-derived mesenchymal stem cells.
    Gu YZ; Xue Q; Chen YJ; Yu GH; Qing MD; Shen Y; Wang MY; Shi Q; Zhang XG
    Hum Immunol; 2013 Mar; 74(3):267-76. PubMed ID: 23261407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of humoral response to allogeneic porcine mesenchymal stem cell with 12 days of tacrolimus.
    Poncelet AJ; Nizet Y; Vercruysse J; Hiel AL; Saliez A; Gianello P
    Transplantation; 2008 Dec; 86(11):1586-95. PubMed ID: 19077894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of clinically relevant doses of immunosuppressive drugs on human mesenchymal stem cells.
    Javorkova E; Vackova J; Hajkova M; Hermankova B; Zajicova A; Holan V; Krulova M
    Biomed Pharmacother; 2018 Jan; 97():402-411. PubMed ID: 29091890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum- and xeno-free cryopreservation of human umbilical cord tissue as mesenchymal stromal cell source.
    Shimazu T; Mori Y; Takahashi A; Tsunoda H; Tojo A; Nagamura-Inoue T
    Cytotherapy; 2015 May; 17(5):593-600. PubMed ID: 25881518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of human mesenchymal stem cells from fetal-bone marrow, adipose tissue, and Warton's jelly as sources of cell immunomodulatory therapy.
    Wang Q; Yang Q; Wang Z; Tong H; Ma L; Zhang Y; Shan F; Meng Y; Yuan Z
    Hum Vaccin Immunother; 2016; 12(1):85-96. PubMed ID: 26186552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryopreservation does not alter main characteristics of Good Manufacturing Process-grade human multipotent mesenchymal stromal cells including immunomodulating potential and lack of malignant transformation.
    Luetzkendorf J; Nerger K; Hering J; Moegel A; Hoffmann K; Hoefers C; Mueller-Tidow C; Mueller LP
    Cytotherapy; 2015 Feb; 17(2):186-98. PubMed ID: 25593077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.